← Open Payments lookup

KAMI BELL: Open Payments

NPI 1417355694 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,527 in 68 payments from 11 companies in 2025. Trend: 2023 $1,416 · 2024 $1,569 · 2025 $1,527

Food & beverage: $1,486Education: $41
CompanyPaymentsAmount
ViiV Healthcare Company16$422
Gilead Sciences, Inc.19$383
Merck Sharp & Dohme LLC8$181
Melinta Therapeutics, LLC9$155
Astellas Pharma US Inc5$125
Shionogi Inc3$93
ABBVIE INC.4$90
La Jolla Pharmaceutical Company1$21
Insmed, Inc.1$20
Aimmune Therapeutics, Inc.1$19

Products named: CABENUVA, DOVATO, Rezzayo, ZERBAXA, Fetroja, Cresemba, APRETUDE, AVYCAZ.

Industry payments across MS — which companies pay providers there.